Redmile Group, LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:17 pm Sale | 2025-06-30 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group, LLC | 4,641,455 8.500% | -267,809 (-5.46%) | Filing |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group, LLC | 4,909,264 9.600% | -82,281 (-1.65%) | Filing |
| 2023-10-16 5:15 pm Purchase | 2023-10-04 | 13G | ALX Oncology Holdings Inc. ALXO | Redmile Group, LLC | 4,991,545 9.600% | 4,991,545 (New Position) | Filing |